Evaluating Hyaluronic Acids in Patients with Skin of Color
In the past decade, dermal fillers have quickly defined a new branch of cosmetic dermatology that both patients and physicians enjoy. In this short time, fillers of all types have entered the market, giving patients a variety of options to achieve their desired effects. Physicians now also have wider capacities and increased range to address subtler aspects of facial aesthetics. However, given the great popularity of fillers and opportunities they present, little research has been conducted on their effect in patients with skin of color.
One recent study addresses this area, assessing both the safety and efficacy of hyaluronic acids fillers in skin of color.1 Ahead, lead author Pearl E. Grimes, MD, Director of the Vitiligo and Pigmentation Institute of Southern California, discusses the results and explains why they are significant in the scope of research on dermal fillers.
Why is this study significant?
There was a need for data addressing fillers in
patients of skin of color simply because physicians
know so little about how fillers affect skin of color,
according to Dr. Grimes. She observes that, historically,
fillers are known for safety when used properly,
but data are needed to confirm that in skin of
color. “We had no reason to believe that hyaluronic
acids in patients with skin of color would result in
drastic differences, but little data exists to demonstrate
that,” she notes.
While the differences between white skin and skin of color are not significant, Dr. Grimes observes that there are basic differences in skin of color that might impact the delivery and effectiveness of fillers. “The basic skin morphology is different, and we have found that the dermis tends to be thicker in skin of color,” says Dr. Grimes. Therefore, it is worthwhile to consider how fillers take effect when injected into a thicker dermis and how long results last, she says.
What was the study design?
What did you find?
The article actually chronicles two different studies
based on patients from two different databases,
according to Dr. Grimes. In the first, patients were
injected with high concentration (24mg/mL) doses
of either Juvéderm Ultra, Juvéderm Ultra Plus, or
Juvéderm 30 in one nasolabial fold and a Zyplast
collagen injection in the other. In the other study,
patients received one of three low-concentration
(5.5 mg/mL) hyaluronic acids in both nasolabial
folds. The fillers were Hylaform, Hylaform Plus,
and Captique. “The results of both studies showed
great efficacy with all of the hyaluronic acids,”
says Dr. Grimes.
Also, in both studies, Dr. Grimes points out, there was no significant increase in hyperpigmentation (three patients), and the incidence of keloids and hypertrophic scarring was also quite low, she notes. “In general, based on these two studies, we can deduce that the acute side effects profile for hyaluronic acids in skin of color is comparable to white skin,” says Dr. Grimes.
Also, in both studies, Dr. Grimes points out, there was no significant increase in hyperpigmentation (three patients), and the incidence of keloids and hypertrophic scarring was also quite low, she notes. “In general, based on these two studies, we can deduce that the acute side effects profile for hyaluronic acids in skin of color is comparable to white skin,” says Dr. Grimes.
How will the increased prominence in
research on skin of color affect the continued
development of dermal fillers?
Dr. Grimes observes that as delivery methods
and filler technology continue to develop, it
will likely evolve with the shifting demographics
of the overall population in the US. “In
roughly 40 years, more than half of the US
population will be individuals with skin of
color,” explains Dr. Grimes. Therefore, as procedures
are researched and performed today,
it's important to establish a safety and efficacy
profile for filler agents in skin of color so that
it may lead to new research and approaches.
According to Dr. Grimes, this research will be instrumental in paving the way for new agents to come to the market. Ultimately, she says, physicians bear the responsibility to set the learning curve for aesthetic procedures. “It is up to us as researchers to facilitate and establish these standards so that agents in the future cater to patients of all skin types,” explains Dr. Grimes.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Stefan H. Jacobson, MD, PhD
Carlos Narváez Mejía, MD
- General Topics
More than Skin Deep: Sharing Stories for Mental Health
Emily Woolhiser
Alexandra Lawlor
- ISDPA Midwest Derm 2024
ISDPA: Dr. Lio on Alternative and Innovative Approaches
Peter A. Lio, MD
- ISDPA Midwest Derm 2024
ISDPA: Dr. Bhatia and Dr. Zirwas Discuss the Itchy Patient
Neal Bhatia, MD, FAAD
Matthew Zirwas, MD